Literature DB >> 20231910

Simple optimal weighting of cases and controls in case-control studies.

Sherri Rose1, Mark J van der Laan.   

Abstract

Researchers of uncommon diseases are often interested in assessing potential risk factors. Given the low incidence of disease, these studies are frequently case-control in design. Such a design allows a sufficient number of cases to be obtained without extensive sampling and can increase efficiency; however, these case-control samples are then biased since the proportion of cases in the sample is not the same as the population of interest. Methods for analyzing case-control studies have focused on utilizing logistic regression models that provide conditional and not causal estimates of the odds ratio. This article will demonstrate the use of the prevalence probability and case-control weighted targeted maximum likelihood estimation (MLE), as described by van der Laan (2008), in order to obtain causal estimates of the parameters of interest (risk difference, relative risk, and odds ratio). It is meant to be used as a guide for researchers, with step-by-step directions to implement this methodology. We will also present simulation studies that show the improved efficiency of the case-control weighted targeted MLE compared to other techniques.

Entities:  

Mesh:

Year:  2008        PMID: 20231910      PMCID: PMC2835459          DOI: 10.2202/1557-4679.1115

Source DB:  PubMed          Journal:  Int J Biostat        ISSN: 1557-4679            Impact factor:   0.968


  11 in total

1.  Statistics in epidemiology: the case-control study.

Authors:  N E Breslow
Journal:  J Am Stat Assoc       Date:  1996-03       Impact factor: 5.033

Review 2.  Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies.

Authors:  Sander Greenland
Journal:  Am J Epidemiol       Date:  2004-08-15       Impact factor: 4.897

3.  Estimation based on case-control designs with known prevalence probability.

Authors:  Mark J van der Laan
Journal:  Int J Biostat       Date:  2008       Impact factor: 0.968

4.  Why match? Investigating matched case-control study designs with causal effect estimation.

Authors:  Sherri Rose; Mark J van der Laan
Journal:  Int J Biostat       Date:  2009-01-06       Impact factor: 0.968

5.  On the estimation and use of propensity scores in case-control and case-cohort studies.

Authors:  Roger Månsson; Marshall M Joffe; Wenguang Sun; Sean Hennessy
Journal:  Am J Epidemiol       Date:  2007-05-15       Impact factor: 4.897

6.  A method of estimating comparative rates from clinical data; applications to cancer of the lung, breast, and cervix.

Authors:  J CORNFIELD
Journal:  J Natl Cancer Inst       Date:  1951-06       Impact factor: 13.506

7.  The case-control study as data missing by design: estimating risk differences.

Authors:  S Wacholder
Journal:  Epidemiology       Date:  1996-03       Impact factor: 4.822

8.  The effect of disease-prevalence adjustments on the accuracy of a logistic prediction model.

Authors:  A P Morise; G A Diamond; R Detrano; M Bobbio; E Gunel
Journal:  Med Decis Making       Date:  1996 Apr-Jun       Impact factor: 2.583

9.  A comparison of three approaches to estimate exposure-specific incidence rates from population-based case-control data.

Authors:  J Benichou; S Wacholder
Journal:  Stat Med       Date:  1994 Mar 15-Apr 15       Impact factor: 2.373

10.  Causal analysis of case-control data.

Authors:  Stephen C Newman
Journal:  Epidemiol Perspect Innov       Date:  2006-01-27
View more
  19 in total

1.  Estimation and testing of the relative risk of disease in case-control studies with a set of k matched controls per case with known prevalence of disease.

Authors:  Barry Kurt Moser; Susan Halabi
Journal:  Stat Med       Date:  2011-12-09       Impact factor: 2.373

2.  Why match? Investigating matched case-control study designs with causal effect estimation.

Authors:  Sherri Rose; Mark J van der Laan
Journal:  Int J Biostat       Date:  2009-01-06       Impact factor: 0.968

3.  Collaborative double robust targeted maximum likelihood estimation.

Authors:  Mark J van der Laan; Susan Gruber
Journal:  Int J Biostat       Date:  2010-05-17       Impact factor: 0.968

4.  Natural history of diseases: Statistical designs and issues.

Authors:  Nicholas P Jewell
Journal:  Clin Pharmacol Ther       Date:  2016-08-18       Impact factor: 6.875

5.  A general framework for two-stage analysis of genome-wide association studies and its application to case-control studies.

Authors:  James M S Wason; Frank Dudbridge
Journal:  Am J Hum Genet       Date:  2012-05-04       Impact factor: 11.025

6.  Analysis of case-control association studies with known risk variants.

Authors:  Noah Zaitlen; Bogdan Pasaniuc; Nick Patterson; Samuela Pollack; Benjamin Voight; Leif Groop; David Altshuler; Brian E Henderson; Laurence N Kolonel; Loic Le Marchand; Kevin Waters; Christopher A Haiman; Barbara E Stranger; Emmanouil T Dermitzakis; Peter Kraft; Alkes L Price
Journal:  Bioinformatics       Date:  2012-05-03       Impact factor: 6.937

7.  A targeted maximum likelihood estimator for two-stage designs.

Authors:  Sherri Rose; Mark J van der Laan
Journal:  Int J Biostat       Date:  2011-03-11       Impact factor: 0.968

8.  Rose and van der Laan respond to "Some advantages of the relative excess risk due to interaction".

Authors:  Sherri Rose; Mark van der Laan
Journal:  Am J Epidemiol       Date:  2014-01-31       Impact factor: 4.897

9.  A double robust approach to causal effects in case-control studies.

Authors:  Sherri Rose; Mark van der Laan
Journal:  Am J Epidemiol       Date:  2014-01-31       Impact factor: 4.897

10.  Estimating the Effect of a Community-Based Intervention with Two Communities.

Authors:  Mark J van der Laan; Maya Petersen; Wenjing Zheng
Journal:  J Causal Inference       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.